H Niibe Selected Research

H Niibe Research Topics

5	Neoplasms (Cancer) 01/2001 - 01/2000
4	Hyperthermia 09/2002 - 01/2001
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2001 - 04/2000
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2002 - 05/2000
3	Primitive Neuroectodermal Tumors (PNET) 03/2000 - 01/2000
2	Neoplasm Metastasis (Metastasis) 09/2002 - 08/2001
2	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 05/2001 - 05/2000
2	Carcinoma (Carcinomatosis) 01/2001 - 01/2001
1	Squamous Cell Carcinoma of Head and Neck 01/2001
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2001
1	Papillomavirus Infections 01/2001
1	Hemorrhage 07/2000
1	Pain (Aches) 07/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2000
1	Prostatic Neoplasms (Prostate Cancer) 07/2000
1	Jaundice (Icterus) 07/2000
1	Glioblastoma (Glioblastoma Multiforme) 03/2000
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2000

3	Proteins (Proteins, Gene)FDA Link 05/2001 - 01/2000
1	CR 6IBA 09/2002
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2001
1	DNA (Deoxyribonucleic Acid)IBA 05/2001
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2001
1	Hematoxylin (Haematoxylon)IBA 05/2001
1	Caffeine (No Doz)FDA LinkGeneric 05/2000
1	Radiation-Sensitizing AgentsIBA 05/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2000
1	nedaplatinIBA 03/2000
1	Docetaxel (Taxotere)FDA Link 03/2000
1	Etoposide (VP 16)FDA LinkGeneric 01/2000

9	Radiotherapy 09/2002 - 04/2000
3	Brachytherapy 01/2001 - 04/2000
2	Therapeutics 07/2000 - 04/2000
1	Induced Hyperthermia (Thermotherapy) 05/2001
1	Chemoradiotherapy 01/2001
1	Length of Stay 07/2000
1	Aftercare (After-Treatment) 01/2000